View Financial HealthIMAGIS 配当と自社株買い配当金 基準チェック /06IMAGIS配当金を支払った記録がありません。主要情報n/a配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesNew Risk • Jun 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₩14.9b (US$9.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (36% increase in shares outstanding). Market cap is less than US$10m (₩14.9b market cap, or US$9.67m). Minor Risk Share price has been volatile over the past 3 months (16% average weekly change).Board Change • Apr 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Feb 13IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South KoreaNew Risk • Aug 26New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Market cap is less than US$100m (₩20.6b market cap, or US$14.8m).New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₩19.3b market cap, or US$14.0m).お知らせ • Aug 11IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion.IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 5,652,655 Price\Range: KRW 858 Security Name: Common Stock Security Type: Common Stock Securities Offered: 647,345 Price\Range: KRW 858 Transaction Features: Rights OfferingBoard Change • May 26Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.お知らせ • Apr 26IMAGIS Co., Ltd. announced that it has received KRW 999.999675 million in fundingOn April 25, 2025, IMAGIS Co., Ltd., closed the transaction.お知らせ • Apr 17IMAGIS Co., Ltd. announced that it expects to receive KRW 999.999675 million in fundingIMAGIS Co., Ltd. announces private placement to issue 687,285 Common Shares at a price of KRW 1,455 for gross proceeds of KRW 999,999,675 on April 17, 2025. Expected date of the closing is April 25, 2025.お知らせ • Feb 27815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul.815 Life & Health Co., Ltd. and others agreed to acquire 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul for KRW 22.0 billion on December 12, 2024. A cash consideration valued at KRW 5432 per share will be paid by 815 Life & Health Co., Ltd. As part of consideration, an KRW 22 billion value is paid towards common equity of IMAGIS Co., Ltd. The expected completion of the transaction is March 25, 2025. As of January 24, 2025, the transaction closing date is expected on February 25, 2025. 815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul on February 26, 2025. The cancellation occurred due to non-payment of the balance of the transfer company's stock sale.お知らせ • Feb 12IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South KoreaNew Risk • Nov 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩52.8b market cap, or US$38.5m).New Risk • Sep 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩39.6b market cap, or US$29.8m).New Risk • Aug 31New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩34.7b market cap, or US$26.0m).New Risk • Apr 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩48.7b market cap, or US$35.3m).New Risk • Jul 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Market cap is less than US$100m (₩41.5b market cap, or US$31.9m).Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Feb 09IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021, at 10:00 Korea Standard Time.Is New 90 Day High Low • Jan 29New 90-day low: ₩2,210The company is down 17% from its price of ₩2,650 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 46% over the same period.Is New 90 Day High Low • Nov 17New 90-day low: ₩2,485The company is down 14% from its price of ₩2,880 on 19 August 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 19% over the same period.Is New 90 Day High Low • Oct 30New 90-day low: ₩2,650The company is down 16% from its price of ₩3,145 on 31 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is down 3.0% over the same period.決済の安定と成長配当データの取得安定した配当: A115610の 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: A115610の配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場IMAGIS 配当利回り対市場A115610 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (A115610)n/a市場下位25% (KR)1.6%市場トップ25% (KR)4.7%業界平均 (Semiconductor)0.3%アナリスト予想 (A115610) (最長3年)n/a注目すべき配当: A115610は最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: A115610は最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: A115610の 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: A115610が配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YKR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/31 17:22終値2026/07/31 00:00収益2019/12/31年間収益2019/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋IMAGIS Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
New Risk • Jun 26New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₩14.9b (US$9.67m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (36% increase in shares outstanding). Market cap is less than US$10m (₩14.9b market cap, or US$9.67m). Minor Risk Share price has been volatile over the past 3 months (16% average weekly change).
Board Change • Apr 30Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Feb 13IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea
New Risk • Aug 26New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Shareholders have been substantially diluted in the past year (50% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Market cap is less than US$100m (₩20.6b market cap, or US$14.8m).
New Risk • Aug 13New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (8.0% average weekly change). Market cap is less than US$100m (₩19.3b market cap, or US$14.0m).
お知らせ • Aug 11IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion.IMAGIS Co., Ltd. has completed a Follow-on Equity Offering in the amount of KRW 5.4054 billion. Security Name: Common Stock Security Type: Common Stock Securities Offered: 5,652,655 Price\Range: KRW 858 Security Name: Common Stock Security Type: Common Stock Securities Offered: 647,345 Price\Range: KRW 858 Transaction Features: Rights Offering
Board Change • May 26Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
お知らせ • Apr 26IMAGIS Co., Ltd. announced that it has received KRW 999.999675 million in fundingOn April 25, 2025, IMAGIS Co., Ltd., closed the transaction.
お知らせ • Apr 17IMAGIS Co., Ltd. announced that it expects to receive KRW 999.999675 million in fundingIMAGIS Co., Ltd. announces private placement to issue 687,285 Common Shares at a price of KRW 1,455 for gross proceeds of KRW 999,999,675 on April 17, 2025. Expected date of the closing is April 25, 2025.
お知らせ • Feb 27815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul.815 Life & Health Co., Ltd. and others agreed to acquire 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul for KRW 22.0 billion on December 12, 2024. A cash consideration valued at KRW 5432 per share will be paid by 815 Life & Health Co., Ltd. As part of consideration, an KRW 22 billion value is paid towards common equity of IMAGIS Co., Ltd. The expected completion of the transaction is March 25, 2025. As of January 24, 2025, the transaction closing date is expected on February 25, 2025. 815 Life & Health Co., Ltd. and others cancelled the acquisition of 24.92% stake in IMAGIS Co., Ltd. (KOSDAQ:A115610) from Kim Jung Chul on February 26, 2025. The cancellation occurred due to non-payment of the balance of the transfer company's stock sale.
お知らせ • Feb 12IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025IMAGIS Co., Ltd., Annual General Meeting, Mar 26, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 105, gwanggyo-ro, yeongtong-gu, gyeonggi-do, suwon South Korea
New Risk • Nov 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (12% average weekly change). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩52.8b market cap, or US$38.5m).
New Risk • Sep 25New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (9.6% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩39.6b market cap, or US$29.8m).
New Risk • Aug 31New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩34.7b market cap, or US$26.0m).
New Risk • Apr 23New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.7% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Shareholders have been diluted in the past year (2.7% increase in shares outstanding). Market cap is less than US$100m (₩48.7b market cap, or US$35.3m).
New Risk • Jul 06New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2019 fiscal period end). Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risk Market cap is less than US$100m (₩41.5b market cap, or US$31.9m).
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. No highly experienced directors. No independent directors (6 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Feb 09IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021IMAGIS Co., Ltd., Annual General Meeting, Mar 23, 2021, at 10:00 Korea Standard Time.
Is New 90 Day High Low • Jan 29New 90-day low: ₩2,210The company is down 17% from its price of ₩2,650 on 30 October 2020. The South Korean market is up 33% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 46% over the same period.
Is New 90 Day High Low • Nov 17New 90-day low: ₩2,485The company is down 14% from its price of ₩2,880 on 19 August 2020. The South Korean market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 19% over the same period.
Is New 90 Day High Low • Oct 30New 90-day low: ₩2,650The company is down 16% from its price of ₩3,145 on 31 July 2020. The South Korean market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is down 3.0% over the same period.